Peritoneal dialysis in patients with acute or chronic renal failure
Who receives it
Adults
Adult administration
1. The attending physician should adjust the treatment method, number of treatments, exchange volume, dialysis time, and duration according to the patient's symptoms.
2. Use as a solution for peritoneal instillation for dialysis treatment.
3. The dose varies according to body size, and the frequency of fluid exchanges should be appropriately adjusted based on biochemical parameters and fluid balance. In general, in adults, 1.5~2.5L is instilled into the peritoneal cavity per exchange and left in place for 4~8 hours before drainage; this process is performed 3~5 times daily.
4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume.
5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.
Peritoneal dialysis in patients with acute or chronic renal failure
View approved original textHide original text
This medication is used for peritoneal dialysis in patients with acute and chronic renal failure. It effectively removes waste and excess fluid from the bloodstream of patients with impaired kidney function, helping to stabilize their condition. The peritoneal dialysis solution plays a crucial role in replacing renal function, thus improving the healthcare management of patients with renal failure.
How it is given
Adult administration
1. The attending physician should adjust the treatment method, number of treatments, exchange volume, dialysis time, and duration according to the patient's symptoms.
2. Use as a solution for peritoneal instillation for dialysis treatment.
3. The dose varies according to body size, and the frequency of fluid exchanges should be appropriately adjusted based on biochemical parameters and fluid balance. In general, in adults, 1.5~2.5L is instilled into the peritoneal cavity per exchange and left in place for 4~8 hours before drainage; this process is performed 3~5 times daily.
4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume.
5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.
Precautions
This drug is a dialysis solution used for peritoneal dialysis, aiding in the removal of waste products from the body in patients with severely impaired kidney function.
Sudden cessation of peritoneal dialysis may pose a life-threatening risk; therefore, it should not be stopped prematurely unless alternative renal replacement therapies are in place.
It should not be used in patients with defects of the diaphragm or severe abdominal burns, or those with severe abdominal adhesions as this may lead to respiratory difficulties or reduced dialysis efficiency.
Patients with a tendency to bleed, lactic acidosis, severe hypokalemia, or hypocalcemia should not use this medication.
Recent abdominal surgeries, severe inflammation, abdominal fistulae, tumors, bowel obstructions, severe pulmonary diseases, sepsis, or significant weight loss necessitate careful assessment prior to use.
This medication must be used precisely as directed by a physician, and aseptic techniques must be observed to avoid risks of peritonitis or infection.
During dialysis, it is necessary to periodically check weight, serum electrolyte levels, blood glucose, and protein levels for any abnormalities.
Patients using this medication may experience side effects such as abdominal pain, bleeding, peritonitis, electrolyte imbalance, gastrointestinal symptoms, respiratory distress, and edema.
In particular, patients taking digitalis medications or with glucose metabolism disorders should frequently monitor their potassium levels and blood glucose levels.
Women who are pregnant or breastfeeding should only use this medication when the benefits outweigh the risks, as safety has not been established.
Dosing for pediatric patients should be adjusted according to age and weight, while elderly patients should consider the risk of hernia before initiating peritoneal dialysis.
The dialysis solution should be used directly from the provided container, and should not be used if the packaging is damaged or if the solution is cloudy.
The peritoneal dialysis solution should be warmed to body temperature before use and stored at room temperature, avoiding direct sunlight and freezing.
Excessive dosing or rapid exchanges may lead to dehydration, electrolyte imbalances, or hyperglycemia, and if abnormalities occur, immediate medical attention should be sought.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.